Sitemap
December 05, 2008 Articles
Filter by Available Specialty
- Anti-VEGF well tolerated for treating neovascular AMD in year 3 of VISION trial
- FDA advisory committee recommends approval of besifloxacin drop for bacterial conjunctivitis
- No consensus found in attitudes, practices regarding off-protocol therapy
- Once-daily bromfenac fails to reach significance in endpoints in one arm of trial program
- Opko Health completes enrollment for phase 3 trial of compound for AMD treatment
- Patients with degenerative disc disease genetically different than those without the condition
- The cause of his osteoporosis was only skin deep
- Vandetanib improved PFS slightly when combined with paclitaxel and carboplatin